Stock listing
VRCA Stock Price, News, Filings & Events — Verrica Pharmaceuticals Inc.
Selected listing: VRCA · NASDAQ · USD · US
This page tracks Verrica Pharmaceuticals Inc.'s VRCA:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following VRCA:NASDAQ. VRCA:NASDAQ is the stock-level entry point for investors researching Verrica Pharmaceuticals Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Verrica Pharmaceuticals Inc. is a public company traded under the ticker VRCA in the American market. The company has a market capitalization of approximately $86.2 million. Verrica focuses on developing and commercializing innovative therapies for skin diseases.
- Ticker
- VRCA:NASDAQ
- Asset type
- Stock
- Market cap
- $84.3M
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- NASDAQ
- Currency
- USD
Verrica Pharmaceuticals Inc. VRCA:NASDAQ stock context
This page tracks Verrica Pharmaceuticals Inc.'s VRCA:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following VRCA:NASDAQ. VRCA:NASDAQ is the stock-level entry point for investors researching Verrica Pharmaceuticals Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Verrica Pharmaceuticals Inc. is a public company traded under the ticker VRCA in the American market. The company has a market capitalization of approximately $86.2 million. Verrica focuses on developing and commercializing innovative therapies for skin diseases.
Latest news from Verrica Pharmaceuticals Inc.
Verrica Pharmaceuticals to Present YCANTH® and VP-315 Data at Two Upcoming Dermatology Conferences
September 10, 2026
Verrica Pharmaceuticals to Participate in the H.C. Wainwright 28th Annual Global Investment Conference
September 8, 2026
Verrica Pharmaceuticals Announces Completion of Enrollment in First Pivotal Phase 3 Trial (COVE-2) Evaluating YCANTH® for the Treatment o...
August 27, 2026
Verrica Pharmaceuticals Reports Second Quarter 2026 Financial Results
August 6, 2026
Verrica Pharmaceuticals Closes Credit Facility For Up To $27.5 Million in Non-Dilutive Growth Capital
August 6, 2026
Verrica Pharmaceuticals Inc. earnings calls
Verrica Pharmaceuticals Inc. (VRCA) Q2 2026 Earnings Call
August 6, 2026 · Replay with transcript and chapters
Verrica Pharmaceuticals Inc. (VRCA) Q1 2026 Earnings Call
May 12, 2026 · Replay with transcript and chapters
Verrica Pharmaceuticals Inc. (VRCA) Q4 2025 Earnings Call
March 11, 2026 · Replay with transcript and chapters
Verrica Pharmaceuticals Inc. (VRCA) Q3 2025 Earnings Call
November 17, 2025 · Replay with transcript and chapters
Verrica Pharmaceuticals Inc. (VRCA) Q2 2025 Earnings Call
August 12, 2025 · Replay with transcript and chapters
Verrica Pharmaceuticals Inc. (VRCA) Q1 2025 Earnings Call
May 13, 2025 · Replay with transcript and chapters
Research Verrica Pharmaceuticals Inc.
Verrica Pharmaceuticals Inc. investor report
Review AI stock analysis and investor report context for VRCA:NASDAQ.
Verrica Pharmaceuticals Inc. company profile
View the public company page for Verrica Pharmaceuticals Inc. on 6ix.
Verrica Pharmaceuticals Inc. news
Read company news and market updates connected to Verrica Pharmaceuticals Inc..
Verrica Pharmaceuticals Inc. investor events
Find investor webinars, events, and replay context for Verrica Pharmaceuticals Inc..
Alternate listings
A41A98:LS
DE · EUR
Alternate listing for Verrica Pharmaceuticals Inc.; the primary context on this page is VRCA:NASDAQ.
1NE0:TRADEGATE
DE · EUR
Alternate listing for Verrica Pharmaceuticals Inc.; the primary context on this page is VRCA:NASDAQ.
VRCA:BOATS
US · USD
Alternate listing for Verrica Pharmaceuticals Inc.; the primary context on this page is VRCA:NASDAQ.
1NE0:GETTEX
DE · EUR
Alternate listing for Verrica Pharmaceuticals Inc.; the primary context on this page is VRCA:NASDAQ.
A41A98:LSX
DE · EUR
Alternate listing for Verrica Pharmaceuticals Inc.; the primary context on this page is VRCA:NASDAQ.
1NE0:FWB
DE · EUR
Alternate listing for Verrica Pharmaceuticals Inc.; the primary context on this page is VRCA:NASDAQ.
1NE0:SWB
DE · EUR
Alternate listing for Verrica Pharmaceuticals Inc.; the primary context on this page is VRCA:NASDAQ.
1NE0:MUN
DE · EUR
Alternate listing for Verrica Pharmaceuticals Inc.; the primary context on this page is VRCA:NASDAQ.